staining. In contrast, the broad-spectrum caspase inhibitor IDN6734 was not protective in this model. To ascertain whether mitochondrial dysfunction downstream of these events was a required step, we utilized a peptide corresponding to residues 4-23 of Bcl-x L conjugated to the protein transduction domain of HIV TAT (TAT-BH4), which has been shown to protect mitochondria against Ca ++ -induced ∆Ψ m loss (2). TAT-BH4 attenuated CK release and loss of TTC staining, demonstrating the role of mitochondria and a pro-apoptotic Bcl-2 family member in the process leading to cell death. We propose the following pathway: Reperfusion results in sodium influx followed by calcium accumulation; this leads to calpain activation which in turn leads to Bid cleavage; Bid targets the mitochondria, causing dysfunction and release of proapoptotic factors, resulting in DNA fragmentation and death of the cell. Ischemia/reperfusion initiates a cell death pathway that is independent of caspases but requires calpain and mitochondrial dysfunction.
BACKGROUND
Programmed cell death is a widespread process in physiologic and pathologic settings.
We described the occurrence of apoptosis in the ischemic and reperfused heart (3) . Subsequent studies have shown that caspases are critical effectors in apoptosis, and many investigators have concluded that apoptosis can be operationally defined as caspase-dependent cell death. Caspases have been implicated in the pathologic death that follows ischemic injury (4) (5) (6) (7) (8) (9) . However, controversy rages over the relative contributions of apoptosis and necrosis to overall tissue death (10) (11) (12) . Caspase inhibitors have been shown to decrease DNA fragmentation detected by TUNEL labeling; however, the effect on infarct size has been modest, implying that other pathways to death must exist.
Interventions to block sodium influx via inhibition of the sodium/hydrogen exchanger with ethylisopropylamiloride (EIPA) or related compounds such as cariporide have been shown to be protective (reviewed in (13;14) ). The protective effect depends upon the limitation of secondary calcium influx (14) (15) (16) (17) . Less is known about their effects on activation of caspases and calpains. It is reasonable to predict that inhibition of the sodium/hydrogen exchanger would limit calpain activation; however, this has not been formally demonstrated.
Calpain has long been recognized to be an important mediator in "necrotic" cell death, and calpain inhibitors are known to reduce infarct size (18) . We recently showed that calpain was able to cleave the BH3-only family member, Bid, to an active form capable of mediating cytochrome c release (1) . Several investigators have shown that calpain cleaves a variety of proteins to promote apoptosis (19) (20) (21) (22) (23) (24) . These observations support the notion that there is crosstalk between apoptotic and necrotic pathways and that calpain could contribute to apoptosis even by guest on November 19, 2017 http://www.jbc.org/ Downloaded from in the presence of caspase inhibition. While cytochrome c release has been considered to be the major consequence of Bid's interaction with mitochondria, other mediators are simultaneously released that may play a role in committing the cell to death; these mediators include Smac/Diablo (25;26), AIF (27) , Omi/Htr A2 (28) , and endonuclease G (29) . Additionally, the loss of cytochrome c will result in an inability to perform oxidative phosphorylation (30) and possibly also increased production of reactive oxygen species (31) . Finally, mitochondrial dysfunction associated with irreversible opening of the permeability transition pore is strongly correlated with cell death (32) , and interventions to prevent pore opening have been shown to protect the myocardium (33) .
Mitochondrial dysfunction and permeability transition pore opening is regulated in part by the voltage-dependent anion channel of the outer mitochondrial membrane (VDAC) (reviewed in (32) ). Oxidative stress as would be encountered in ischemia and reperfusion has been shown to trigger VDAC-dependent mitochondrial dysfunction (34) and opening of the permeability transition pore (35) . VDAC participation in pore opening is regulated by pro-and anti-apoptotic Bcl-2 family members (36) . Recently Shimizu et al. used a peptide corresponding to the anti-apoptotic Bcl-2 homology domain 4 (BH4) of Bcl-x L to prevent VDAC opening (2).
The peptide was delivered intracellularly by covalently coupling it to the protein transduction domain of HIV TAT (37) . We reasoned that if VDAC-dependent mitochondrial dysfunction is an essential aspect of ischemic injury, then preservation of mitochondrial integrity by the TAT-BH4 peptide should be cardioprotective.
Efforts to distinguish apoptosis, necrosis, and oncosis have engendered considerable controversy. In this study we have assessed tissue death by loss of TTC staining and release of CK, but have not attempted to define individual cell death events by morphologic criteria.
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However, we note that DNA fragmentation occurs and correlates with the degree of injury or protection measured by TTC staining or CK release. Our focus has been on the identification of specific sequential events that are amenable to inhibition, with attendant cardioprotective effects.
We have examined the effects of inhibition of the sodium hydrogen exchanger on calpain activation, the effects of calpain and caspase inhibitors on Bid cleavage, DNA fragmentation, and tissue injury, and on the ability of TAT-BH4 to attenuate tissue injury, in order to gain insight into the sequence and hierarchy of cell death events in the ischemic and reperfused heart. 
MATERIALS AND METHODS

Heart perfusion and ischemia/reperfusion protocol
Male New Zealand White rabbits (2.0-2.5 kg) or male Sprague-Dawley rats (200-250 g) were utilized for the preparation of Langendorff-perfused hearts. The experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and all experimental procedures were approved by the Scripps Research Institute Animal Care and Use Committee. The animal was anesthetized and the heart rapidly excised and mounted onto a Langendorff heart perfusion apparatus using a protocol adapted from Tsuchida et al. (38) . The heart was perfused at a constant pressure of 60 mm Hg with KrebsRinger buffer (KRB) consisting of (in mmol/liter) NaCl (118) (25) , and glucose (11) . The perfusate was bubbled with a mixture of 95% O 2 and 5% CO 2 at 37°C. Perfused hearts were stabilized for 15 min and then subjected to global ischemia for 30 min by turning off the perfusion system. After 30 min of ischemia, the perfusion system was restarted, and the hearts were reperfused for the indicated time.
Inhibitors were added to the perfusion buffer 10 min before ischemia and included in the reperfusion buffer. Inhibitors were as follows: calpain inhibitor I or III (10 µM) (ALLN or CI3, respectively, Calbiochem, San Diego, CA); caspase inhibitor (20 µM) (IDN6734, generously provided by Idun Pharmaceuticals, San Diego); and 5-(N-ethyl-N-isopropyl)amiloride (EIPA) (5 µM) (Sigma Chemicals). To examine the effect of Bcl-x L on infarct size, we used a cellpermeable peptide that contains the conserved N-terminal homology domain (BH4) of Bcl-x L linked to HIV-TAT sequence (TAT-BH4, Calbiochem, San Diego). TAT-BH4 (50 nM) was included in the perfusion buffer for 15 min following the initial equilibration period, and then washed out with KRB buffer for 10 min before ischemia and reperfusion. TAT-BH4 was not included in the reperfusion buffer.
Creatine kinase activity and infarct size measurement
Coronary effluent was collected for 15 min before ischemia and at the beginning of reperfusion. Creatine kinase (CK) activity in coronary effluent was determined using a kit according to the manufacturer's instructions (Sigma Chemicals, St. Louis, MO). The measurement of infarct size using triphenyl tetrazolium staining was essentially identical to that detailed by Downey (39) . The method of quantitation was previously described (40) . Briefly, after the TTC reaction, the heart slices were scanned into TIFF files and analyzed with Adobe Photoshop 5.5. The images were digitally manipulated in an identical manner to ensure equivalent outcome. The histogram counts of red and white were recorded. The percent infarction was calculated as white counts divided by the sum of red plus white counts.
Calpain Activity Assay and Western blot analysis for α-spectrin
Cytosolic fractions were prepared as previously described (1). Calpain activity was measured using 50 µM Suc-Leu-Tyr-7-amino-4-methylcoumarin (Suc-Leu-Tyr-AMC) as the substrate (Calbiochem, San Diego, CA). Cytosol (20 µl = 100 µg of protein) was added to a 100 µl of reaction buffer (145 mM NaCl, 100 mM Tris-HCl, pH 7.3). AMC release was measured over 1 h at room temperature by fluorimetry (Molecular Devices) using 360-nm excitation and 430-nm emission filters. Standard curves were generated for each experiment using known concentrations of AMC. Calpain activity was expressed as nmol AMC released/min/mg protein. All measurements were made in triplicate and repeated with extracts from several independent experiments. For statistical analysis, each heart (consisting of triplicate measurements) was treated as an individual data point. For each analysis, calpain activity was normalized to the control value performed the same day.
For Western Blot Analysis, cytosolic proteins were determined by the Coomassie Blue binding assay (Pierce Chemical Co.) with BSA standards. Samples containing equal amounts of protein were subjected to electrophoresis on 4-20% gradient polyacrylamide gels (Novex) and then transferred to nitrocellulose membrane (Millipore Corp). Blots were incubated with antibody to α-spectrin (Chemicon International, Inc) followed by peroxidase-conjugated secondary antibody.
Single-strand DNA and Bid immunostaining
At the end of perfusion, a coronal median slice 2 mm thick was removed from the heart and immersed in freshly prepared 4 % formaldehyde in KRB over night. A standard histological method was applied to prepare the paraffin-embedded tissue sections. Tissue sections were dewaxed with xylene and rehydrated with graded alcohol. For single-strand DNA staining, tissue sections were treated with saponin (0.1 mg/ml) at room temperature for 20 min followed by 20 min of incubation in proteinase K (20 µg/ml) and 20 min incubation in 50% formamide in water bath at 56ºC, and then transferred to ice-cold PBS for 5 min. After 30 min of incubation in 3% non-fat dry milk, tissue sections were incubated with 10-20 µl (100 µg/ml) mouse monoclonal antibody against single-stranded DNA (Alexis) at room temperature for 30 min, and then incubated with biotinylated anti-mouse IgM antibody (Zymed) followed by Cy2-conjugated streptavidin. Nuclei were counterstained with propidium iodide (PI).
To detect Bid cleavage, tissue sections were deparaffinized and after microwave antigen retrieval were immunostained using a diaminobenzidine-based detection method. The EnvisionRabbit polymer-based complex reagent (Dako) was used as the secondary antibody in an automated immunostainer (Dako Universal Staining System) as previously described (41) .
RESULTS
Effect of caspase and calpain inhibitors on calpain activity
Previously, we showed that calpain activity, but not caspase activity, is increased following myocardial ischemia and reperfusion (1). However, others have shown that caspase inhibitors reduce apoptosis in that context (4-9). To determine if caspase inhibitors affected calpain activity, we perfused hearts with the pan-caspase inhibitor, IDN6734, or with the calpain inhibitor ALLN, then measured calpain activity in cytosolic extracts. As previously published and shown in Fig. 1 , calpain activity increased following I/R. Infusion of ALLN reduced calpain activity substantially, and addition of ALLN directly to the lysate from the I/R heart fully inhibited calpain activity. In contrast, IDN6734 infusion had only a modest effect on calpain activity, and direct addition of IDN6734 to the I/R lysate reduced calpain activity to the same minor extent.
Effect of caspase and calpain inhibitors on myocardial injury
We next assessed the effect of calpain inhibition and caspase inhibition on myocardial injury. Calpain inhibition by perfusion of CI3 reduced CK release by 80%, while IDN6734 had no effect (Fig 2A) . Similar effects on infarct size were seen, with a 50% reduction in infarct size by CI3 infusion, and no reduction of infarct size with infusion of IDN6734 (Fig 2B) . Some investigators have suggested that the presence of single strand DNA breaks serves to distinguish apoptosis from necrosis (42) . In addition, it has been suggested that calpain activation is a feature of "necrotic" death. However, our previous work demonstrated cross-talk between calpain and classical apoptotic pathways. We detected DNA fragmentation using an antibody that recognizes the single-strand breaks and chromatin remodeling considered to be a characteristic feature of apoptosis, in hearts perfused with CI3 or IDN6734 and subjected to I/R.
As shown in Fig 3, CI3 infusion reduced the number of cells with single strand breaks, while IDN6734 had no effect. These results suggested that calpain was responsible for initiating apoptosis, and we turned our attention to its activation.
Effect of EIPA on calpain activation
Inhibition of the sodium hydrogen exchanger is known to be cardioprotective through limitation of calcium influx. We hypothesized that limitation of calcium influx would limit the activation of calpain. Hearts were subjected to I/R in the presence or absence of EIPA, and calpain activity was determined after 15 min reperfusion. We measured calpain activity by cleavage of a synthetic peptide substrate, and restricted our analysis to calcium-independent activity, which would reflect the fraction of calpain that had undergone proteolytic activation in vivo. EIPA infusion suppressed calpain activation back to the level seen in control hearts ( Fig   4A) . Calpain activation is additionally revealed by the cleavage of α-spectrin to yield a 150 kDa fragment (43) . EIPA infusion prevented the cleavage of α-spectrin that otherwise occurred during I/R (Fig 4B) . This result suggested that prevention of sodium influx with its attendant calcium elevation had the important effect of suppressing calpain activation.
Effect of calpain inhibition on Bid cleavage
Previously we showed that Bid was cleaved by calpain in vitro, and that I/R resulted in Bid cleavage. To determine whether Bid cleavage in the heart was mediated by caspases or calpains, we perfused hearts with ALLN or IDN6734 followed by 30 min ischemia and 90 min by guest on November 19, 2017 http://www.jbc.org/ Downloaded from reperfusion. We assessed Bid cleavage using an antibody that recognized intact, full-length Bid but not the cleaved fragments (Fig 5) . Immunostaining of heart sections from heart subjected to 30 min of ischemia and 15 min reperfusion demonstrated partial loss of Bid immunoreactivity, with nearly complete disappearance of Bid after 90 min reperfusion. Calpain inhibition with ALLN preserved Bid immunoreactivity. However, in hearts infused with IDN6734, Bid immunoreactivity was lost to a considerable extent, suggesting that calpain is the protease responsible for most, if not all, of the Bid cleavage in the ischemic heart.
Participation of mitochondria in ischemic injury
The cleaved C-terminal fragment of Bid targets the mitochondria, leading to release of cytochrome c. The changes that accompany cytochrome c release include loss of oxidative phosphorylation capacity, loss of calcium homeostasis, excess superoxide production, and release of additional pro-apoptotic factors including endonucleases. The BH4 domain of Bcl-x L has been shown to be necessary and sufficient for protection against mitochondrial dysfunction and apoptosis, and recently was shown to interact with truncated Bid (22) . We used a TATconjugated BH4 peptide corresponding to amino acids 4-23 of Bcl-x L , which has been shown to protect mitochondria (2) . Hearts perfused with TAT-BH4 demonstrated reduced injury after I/R, as measured by CK release and TTC staining (Fig 6) .
DISCUSSION
Our findings indicate that in this model of 30 min global ischemia and 2 h reperfusion, performed both in rabbit and rat, caspase activation is a minor component of apoptosis and overall tissue injury. Instead, we find that calpain activation is responsible for initiating a mitochondrial-dependent apoptotic program, as suggested by our earlier report (1) and by the report of a similar pathway in ionomycin-induced cell death (22) . Our observations lead us to propose the linear sequence of events depicted in Fig 7. Inhibition of sodium influx has previously been shown to limit calcium influx, and we now demonstrate that this prevents calpain activation. While the calcium elevation itself could target the mitochondria, we show that inhibition of calpain is able to protect the myocardium, indicating that calcium influx itself is not directly responsible for mitochondrial dysfunction and tissue damage. We show that calpain cleaves Bid, which targets the mitochondrion. Bid has been shown to interact with Bcl-x L , although it is not clear whether this involves the BH4 domain (22) .
While Bid is one protein that targets the mitochondria after cleavage by calpain, many other potential targets of calpain exist, both known and unknown. Consistent with observations in cell culture (27) (28) (29) , we suggest that the mitochondria may release factors and reactive oxygen species that cause DNA fragmentation and death in the setting of ischemia and reperfusion.
While cytochrome c release is a cofactor for caspase activation, we suggest that in this setting, other pro-apoptotic factors released from the mitochondria are important mediators of cell death.
We demonstrate that preserving mitochondrial function with the TAT-BH4 peptide is cardioprotective. This is consistent with the findings of others who have shown that Bcl-2 can protect the heart against ischemia/reperfusion injury (44;45).
The critical requirement for mitochondrial participation in the death process is underscored by the protective effect of the mitochondrial ATP-sensitive potassium channel in preconditioning. This channel has been suggested to preserve calcium homeostasis and would therefore limit calpain activation (46) . The massive calcium influx that occurs with reperfusion has been assumed to be responsible for opening of the permeability transition pore, leading to mitochondrial swelling and rupture. However, our observation that calpain inhibition is protective suggests that pore opening, if it occurs, is downstream of calpain activation and Bid cleavage. Further studies will be necessary to identify the mitochondrial factors that mediate irreversible injury.
FIGURE LEGENDS
Fig. 1. Effect of calpain and caspase inhibitors on calpain activity.
Hearts were perfused continuously (Con) or subjected to I/R after being perfused with vehicle (I/R), with IDN6734 (I/R IDNp) or ALLN (I/R ALLNp). Lysates were prepared after 90 min reperfusion and calpain activity was determined. To ascertain the direct effect of the inhibitors on calpain activity, an aliquot of the I/R lysate was incubated with IDN6734 (I/R IDNa) or ALLN (I/R ALLNa) for 10 min before the calpain activity assay was performed. Error bars denote SEM. Hearts were perfusion-fixed and stained as described in the methods. Nuclei were counterstained with PI (inset). Representative fields from 3 independent experiments are shown. 
